250 results on '"BORSETTI, ALESSANDRA"'
Search Results
2. New insights into pathogenesis point to HIV-1 Tat as a key vaccine target
3. Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis
4. Comprehensive Analysis of HIV-1 Integrase Resistance-Related Mutations in African Countries
5. SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy
6. The transmission dynamic of Madariaga Virus by bayesian phylogenetic analysis: Molecular surveillance of an emergent pathogen
7. Phylodynamic and Evolution of the Hemagglutinin (HA) and Neuraminidase (NA) Genes of Influenza A(H1N1) pdm09 Viruses Circulating in the 2009 and 2023 Seasons in Italy.
8. Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis
9. Monitoring Monkeypox: Safeguarding Global Health through Rapid Response and Global Surveillance
10. Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant
11. Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage
12. Joining Forces against Antibiotic Resistance: The One Health Solution
13. Update on the Phylodynamic and Genetic Variability of Marburg Virus
14. Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2
15. HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities
16. Khosta: A Genetic and Structural Point of View of the Forgotten Virus
17. SARS-CoV CH.1.1 Variant: Genomic and Structural Insight
18. Avian Influenza: Could the H5N1 Virus Be a Potential Next Threat?
19. Genome‐based survey of the SARS‐CoV‐2 BF.7 variant from Asia
20. Molecular In-Depth on the Epidemiological Expansion of SARS-CoV-2 XBB.1.5
21. Cellular Immune Profiling of Lung and Blood Compartments in Patients with SARS-CoV-2 Infection
22. Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages
23. Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion
24. Clinical Impact of Colonization with Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Admitted for Severe Trauma
25. Gut Microbiota and COVID-19: Potential Implications for Disease Severity
26. The Biological Properties of the SARS-CoV-2 Cameroon Variant Spike: An Intermediate between the Alpha and Delta Variants
27. Genetic and Structural Data on the SARS-CoV-2 Omicron BQ.1 Variant Reveal Its Low Potential for Epidemiological Expansion
28. Phosphatidylcholine Liposomes Down-Modulate CD4 Expression Reducing HIV Entry in Human Type-1 Macrophages
29. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19
30. Analysis of HIV‐1 integrase genotypes and polymorphisms among integrase inhibitors‐based antiretroviral treatment naïve patients in South Sudan
31. Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients
32. The unresolved question on COVID‐19 virus origin: The three cards game?
33. Sequence Conservation and Antibody Cross-Recognition of Clade B Human Immunodeficiency Virus (HIV) Type 1 Tat Protein in HIV-1-Infected Italians, Ugandans, and South Africans
34. Short- and Long-Term Immunological Responses in Chronic HCV/HIV Co-Infected Compared to HCV Mono-Infected Patients after DAA Therapy
35. Human Immunodeficiency Virus Type 2: The Neglected Threat
36. Advances in SIV/SHIV Non-Human Primate Models of NeuroAIDS
37. The importance of genomic analysis in cracking the coronavirus pandemic
38. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6Pcy243 epitope variability
39. SARS-Cov-2 ORF3a: Mutability and function
40. SARS-CoV-2 Lineages and Sub-Lineages Circulating Worldwide: A Dynamic Overview
41. Animal Hosts and Experimental Models of SARS-CoV-2 Infection
42. Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview
43. SARS-CoV-2 shifting transmission dynamics and hidden reservoirs limited the efficacy of public health interventions in Italy
44. The unresolved question on COVID‐19 virus origin: The three cards game?
45. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine
46. IRF-1 phosphorylation by I-kappa-B kinase epsilon impairs IFN beta stimulation in activated CD4+ T cells.: CS03-5
47. 190 IRF-1 is required for full NF-κB transcriptional activity at the HIV-1 LTR enhancer
48. Tat protein vaccination of cynomolgus macaques influences SHIV-89.6Pcy243epitope variability
49. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
50. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.